Literature DB >> 22232348

Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.

Zografos Caramanos1, Simon James Francis, Sridar Narayanan, Yves Lapierre, Douglas Lorne Arnold.   

Abstract

OBJECTIVE: To better characterize the relationship between cerebral white matter lesion load (CWM-LL) and clinical disability by (1) covering the entire range of the Kurtzke Expanded Disability Status Scale (EDSS), (2) minimizing nonbiological sources of variability, and (3) increasing pathologic specificity by studying CWM lesions that are hypointense on T1-weighted magnetic resonance imaging.
DESIGN: Cross-sectional, retrospective study.
SETTING: Hospital-based multiple sclerosis (MS) clinic. Patients  A total of 110 patients with untreated MS were recruited and studied from June 1, 1997, through June 30, 2003. MAIN OUTCOME MEASURES: Cube-rooted CWM-LL and EDSS-measured clinical disability scores.
RESULTS: We found a large, nonplateauing relationship between cube-rooted CWM-LL and concurrent EDSS scores, more so for T1-hypointense than T2-hyperintense lesions (r = 0.619 vs 0.548). Correlations between the EDSS scores and CWM-LL diminished when, as typically done in clinical trials, only those patients with EDSS scores of 0 to 6.0 were studied (n = 92; r = 0.523 for T1-hypointense lesions and r = 0.457 for T2-hyperintense lesions); more important, a series of boot-strapped correlations suggested that this decrease was not simply due to smaller sample size, and these relationships remained even after correcting for disease duration.
CONCLUSION: A large, nonplateauing relationship exists between CWM-LL and EDSS-measured clinical disability when patients with MS are studied to examine the entire range of disability, minimize nonbiological sources of variability, and increase pathologic specificity.

Entities:  

Mesh:

Year:  2012        PMID: 22232348     DOI: 10.1001/archneurol.2011.765

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

Review 1.  The Relevance of Neuroimaging Findings to Physical Disability in Multiple Sclerosis.

Authors:  Rahşan Göçmen
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

2.  Neuroradiological evaluation of demyelinating disease.

Authors:  Jan-Mendelt Tillema; Istvan Pirko
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

3.  Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.

Authors:  J van Heerden; D Rawlinson; A M Zhang; R Chakravorty; M A Tacey; P M Desmond; F Gaillard
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-18       Impact factor: 3.825

4.  Rotation-invariant multi-contrast non-local means for MS lesion segmentation.

Authors:  Nicolas Guizard; Pierrick Coupé; Vladimir S Fonov; Jose V Manjón; Douglas L Arnold; D Louis Collins
Journal:  Neuroimage Clin       Date:  2015-05-13       Impact factor: 4.881

5.  The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.

Authors:  Amgad Droby; Vinzenz Fleischer; Marco Carnini; Hilga Zimmermann; Volker Siffrin; Joachim Gawehn; Michael Erb; Andreas Hildebrandt; Bernhard Baier; Frauke Zipp
Journal:  Neuroimage Clin       Date:  2015-04-10       Impact factor: 4.881

6.  Peginterferon beta-1a reduces the evolution of MRI lesions to black holes in patients with RRMS: a post hoc analysis from the ADVANCE study.

Authors:  Douglas L Arnold; Xiaojun You; Carmen Castrillo-Viguera
Journal:  J Neurol       Date:  2017-07-07       Impact factor: 4.849

Review 7.  The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.

Authors:  Maria A Rocca; Giancarlo Comi; Massimo Filippi
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

8.  A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.

Authors:  James Kolasinski; Charlotte J Stagg; Steven A Chance; Gabriele C Deluca; Margaret M Esiri; Eun-Hyuk Chang; Jacqueline A Palace; Jennifer A McNab; Mark Jenkinson; Karla L Miller; Heidi Johansen-Berg
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

9.  Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?

Authors:  Nicolò Margaritella; Laura Mendozzi; Massimo Garegnani; Raffaello Nemni; Elena Colicino; Elisabetta Gilardi; Luigi Pugnetti
Journal:  BMC Neurol       Date:  2012-08-22       Impact factor: 2.474

10.  Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.

Authors:  Rezwan Ghassemi; Sridar Narayanan; Brenda Banwell; John G Sled; Manohar Shroff; Douglas L Arnold
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.